sun pharma semaglutide receives DCGI approval for Noveltreat, positioning itself strongly in India's fast-growing GLP-1 weight-management and diabetes therapy market ahead of patent expiry in 2026. #SunPharma #PharmaceuticalIndustry #GLP1 #Semaglutide Sun Pharma Wins DCGI Approval
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19




:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)



.jpg?w=8688&max-h=5792&fit=crop&auto=format)














